Melanotan 2 (MT2) is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone (-MSH)
Food and Drug Administration (" FDA ") Pharmacy Compounding Advisory Committee (PCAC) (the " Committee "), held on July 23 and 24, 2026, recommending that six (6) peptide substances, namely BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, be included on the FDA's 503A Bulks List
Another comprehensive review, which included 37 randomized controlled trials with 2292 participants, examined the effects of L-Carnitine on body weight and composition
DPP-IV inhibitors demonstrate favorable safety and tolerability in extensive phase III clinical studies, with nasopharyngitis and cutaneous lesions as primary adverse events (Scheen, 2018